A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
Keyword(s):
Phase I
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14554-14554
◽
2006 ◽
Vol 5
(7)
◽
pp. 1764-1773
◽
2010 ◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3046-3046
◽
2001 ◽
Vol 37
◽
pp. S74-S75
◽